Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication (CPC)
|ClinicalTrials.gov Identifier: NCT00715273|
Recruitment Status : Active, not recruiting
First Posted : July 15, 2008
Last Update Posted : June 26, 2017
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)
Daiichi Sankyo, Inc.
Information provided by (Responsible Party):
Xue-Qiao Zhao, University of Washington
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||February 2019|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Zhao XQ, Dong L, Hatsukami T, Phan BA, Chu B, Moore A, Lane T, Neradilek MB, Polissar N, Monick D, Lee C, Underhill H, Yuan C. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging. 2011 Sep;4(9):977-86. doi: 10.1016/j.jcmg.2011.06.013.
Dong L, Kerwin WS, Chen H, Chu B, Underhill HR, Neradilek MB, Hatsukami TS, Yuan C, Zhao XQ. Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging. Radiology. 2011 Jul;260(1):224-31. doi: 10.1148/radiol.11101264. Epub 2011 Apr 14.